Literature DB >> 11090840

Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart.

X J Du1, X M Gao, B Wang, G L Jennings, E A Woodcock, A M Dart.   

Abstract

OBJECTIVE: To explore long-term cardiac phenotype in transgenic (TG) mice with 300-fold overexpression of beta(2)-adrenergic receptors (AR).
METHODS: Echocardiography was performed serially on a cohort of wild-type and TG mice (n=26 each) between 4 and 15 months of age. Survival was monitored and autopsy and histological examinations were performed.
RESULTS: Heart rate was higher in TG than in wild-type mice throughout the study period. The left ventricular dimensions and fractional shortening were similar between TG and wild-type groups during 4-6 months. Starting at 9 months, however, TG mice showed progressive reduction in fractional shortening and systolic wall thickening, and increase in left ventricular dimensions and left ventricular mass, indicating onset of heart failure, left ventricular hypertrophy and remodeling. Abnormal waveforms in the electrocardiogram and episodes of ventricular ectopic beats were also observed in TG mice. Death of TG mice started at 8.5 months, and the cumulative mortality was 81% by 15 months (P<0.0001 vs. 4% in wild-type mice). The majority of deaths were due to severe heart failure, indicated by cardiac dilatation, lung congestion, pleural effusion and atrial thrombus. Left ventricular sections showed widespread interstitial fibrosis, loss of myocytes and myocyte hypertrophy in TG mice.
CONCLUSIONS: A high level of beta(2)AR overexpression results in cardiomyopathy and heart failure. The onset was slower and the expression levels of receptors required are much higher than previously described for the beta(1)AR overexpression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090840     DOI: 10.1016/s0008-6363(00)00187-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  32 in total

1.  Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice.

Authors:  Xiao-Jun Du; Timothy J Cole; Nora Tenis; Xiao-Ming Gao; Frank Köntgen; Bruce E Kemp; Jörg Heierhorst
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

3.  Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy.

Authors:  Emanuele Giordano; Rebecca A Hillary; Thomas C Vary; Anthony E Pegg; Andrew D Sumner; Claudio M Caldarera; Xue-Qian Zhang; Jianliang Song; JuFang Wang; Joseph Y Cheung; Lisa M Shantz
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

Review 4.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

Review 5.  Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

Authors:  Stephen F Vatner; Misun Park; Lin Yan; Grace J Lee; Lo Lai; Kousaku Iwatsubo; Yoshihiro Ishikawa; Jeffrey Pessin; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-26       Impact factor: 4.733

6.  Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease.

Authors:  Helen Kiriazis; Nicole L Jennings; Pamela Davern; Gavin Lambert; Yidan Su; Terence Pang; Xin Du; Luisa La Greca; Geoffrey A Head; Anthony J Hannan; Xiao-Jun Du
Journal:  J Physiol       Date:  2012-08-13       Impact factor: 5.182

Review 7.  Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.

Authors:  David Ho; Lin Yan; Kousaku Iwatsubo; Dorothy E Vatner; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 8.  Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure?

Authors:  Samuel Lee; Robert H G Schwinger; Klara Brixius
Journal:  Pflugers Arch       Date:  2007-09-14       Impact factor: 3.657

9.  β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice.

Authors:  Stephen R Spindler; Patricia L Mote; Rui Li; Joseph M Dhahbi; Amy Yamakawa; James M Flegal; Daniel R Jeske; Rui Li; Alex L Lublin
Journal:  Age (Dordr)       Date:  2013-01-15

Review 10.  Adrenergic signaling in heart failure and cardiovascular aging.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Maturitas       Date:  2016-03-26       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.